drugset
drugset / Trial / NCT00945503

Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.

NCT00945503 ↗

Phase 1 Completed 12 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A PET study using \[11c\]GSK931145 to characterise the exposure-occupancy relationship over time for GSK1018921.

Timeline

Start
2008-05-19
Primary completion
2008-12-22
Completion
2008-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1018921 Unknown — —

Indications

schizophrenia